Panion & Bf Biotech Inc.

Taiwan Stock Exchange 1760.TW

Panion & Bf Biotech Inc. EBIT for the year ending December 31, 2023: USD 5.11 M

Panion & Bf Biotech Inc. EBIT is USD 5.11 M for the year ending December 31, 2023, a -54.09% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.

Panion & Bf Biotech Inc. EBIT for the year ending December 31, 2022 was USD 11.13 M, a 54.66% change year over year.
Panion & Bf Biotech Inc. EBIT for the year ending December 31, 2021 was USD 7.19 M, a 107.93% change year over year.
Panion & Bf Biotech Inc. EBIT for the year ending December 31, 2020 was USD 3.46 M, a -54.63% change year over year.
Panion & Bf Biotech Inc. EBIT for the year ending December 31, 2019 was USD 7.63 M, a 9.72% change year over year.

Key data

Date	EBIT	EBITDA	Net Income	EPS (Diluted)

Taiwan Stock Exchange: 1760.TW

Panion & Bf Biotech Inc.

CEO	Mr. Tsung-Ming Chiang
IPO Date	Dec. 20, 2007
Location	Taiwan
Headquarters	Building F
Employees	321
Sector	Health Care
Industries Biotechnology Cosmetics Pharmaceuticals

Description

Panion & Bf Biotech Inc., a biotechnology pharmaceutical company, manufactures and sells various pharmaceutical products in Taiwan. The company offers products in the areas of medical beauty, kidney, respiratory tract, gastrointestinal tract, and body and hair cleaning. It also provides oral drugs and topical preparations; hand and mechanical disinfection, body lotion, and skin disinfection products; and pet health products, including surgical and skin prescriptions. Panion & Bf Biotech Inc. was founded in 1976 and is headquartered in Taipei, Taiwan.

Key trends

Past 5 years